Skip to content

Newron Pharmaceuticals SpA Sustainability Reports

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company conducts proprietary scientific research and clinical trials to bring neurodegenerative and psychiatric drug candidates from discovery to commercialization.

Sector: Professional & technical services

Country: Italy

Exchange: SIX Swiss Exchange

LEI: 8156002F8C11F80A9740

FIGI: BBG001SKJG51

16 reports from 2007 to 2025